Use quotes to search for exact phrases. Use AND/OR/NOT between keywords or phrases for more precise search results.

Michigan Bill Regarding Vaccinations Containing Aborted Fetal Tissue (SB 1055)

This law was last updated on Sep 6, 2018


This law is Anti–Choice

State

Michigan

Number

SB 1055

Status

Failed to Pass

Proposed

Jun 7, 2018

Sponsors

Primary Sponsors: 1
Co-sponsors: 5
Total Sponsors: 6

Topics

Fetal Tissue, Human Embryo and Fetal Research

Full Bill Text

www.legislature.mi.gov

SB 1055 would require the state health department to create and maintain a list of each immunizing agent derived from aborted fetal tissue. The list would also need to include any immunizing agents that are not derived from aborted fetal tissue which can be used as alternatives.

The bill defines “immunizing agent derived from aborted fetal tissue” to mean:

An immunizing agent that is manufactured using a human fetal or embryonic cell line, protein, deoxyribonucleic acid, recombinant deoxyribonucleic acid, monoclonal antibody, or any other component derived from an elective abortion or using a cell line derived from the tissue of a fetus that was electively aborted.

When providing vaccines, a health-care provider would be required to notify the patient if the immunizing agent is derived from aborted fetal tissue, and if available, offer an alternative vaccine which does not derive from aborted fetal tissue.

 


People